Market Place
Sourcing Support
Zealand Pharma to Hold EGM on May 26
01 May 2026 //
GLOBENEWSWIRE
Zealand Pharma Board Proposes Camilla Sylvest For Director Role
01 May 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present Q1 2026 Financial Results
30 Apr 2026 //
GLOBENEWSWIRE
Boehringer, Zealand`s Obesity Drug Resembles Novo`s Wegovy
29 Apr 2026 //
BIOSPACE
Zealand Pharma Reveals Boehringer`s Dual Agonist Survodutide
28 Apr 2026 //
GLOBENEWSWIRE
Roche Backs Amylin Drug for Low-Side-Effect Obesity Care
23 Apr 2026 //
BIOSPACE
Zealand Pharma Insiders Trade Shares, Securities
19 Apr 2026 //
GLOBENEWSWIRE
Zealand Pharma Updates Shares and Voting Rights as of March 31
31 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Sets Up U.S. Research Hub In Cambridge, MA
24 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma Boosts Share Capital Through Employee Warrant
19 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present At March 2026 Investor Conferences
09 Mar 2026 //
GLOBENEWSWIRE
Zealand`s Zupreme serves up to 10.7% mean weight loss
06 Mar 2026 //
GLOBENEWSWIRE
Zealand Pharma convenes its Annual General Meeting 2026
19 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma: Positive Phase 1a Data for ZP9830
18 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma Sets Feb. 19 Call on 2025 Results
12 Feb 2026 //
GLOBENEWSWIRE
Zealand Pharma Utilizes Danish Supercomputer For Drug Discovery
14 Jan 2026 //
INDPHARMAPOST
Zealand Pharma Partners With DCAI For Gefion AI Supercomputer
09 Jan 2026 //
GLOBENEWSWIRE
Zealand Pharma To Present At J.P. Morgan Healthcare Conference
05 Jan 2026 //
GLOBENEWSWIRE
Zealand Pharma Reports Shares, Voting Rights as of Dec. 31, 2025
31 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Managers Engage In Share Transactions
19 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Unveils Metabolic Frontier 2030 Strategy
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma, OTR Therapeutics Ink Metabolic Collaboration
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma Boosts Share Capital Through Employee Warrant
11 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma to Accelerate Drug Development for obesity
11 Dec 2025 //
REUTERS
Zealand Pharma Managers Engage In Share Transactions
05 Dec 2025 //
GLOBENEWSWIRE
Zealand Pharma To Host Capital Markets Day On Dec 11, 2025
01 Dec 2025 //
GLOBENEWSWIRE
Zealand Pumps Brakes On Development Of Dual GLP-1/GLP-2 Agonist
13 Nov 2025 //
FIERCE BIOTECH
Zealand Pharma To Join Jefferies Global Healthcare Conference
12 Nov 2025 //
GLOBENEWSWIRE
Zealand Pharma To Present Q3 2025 Financial Results
06 Nov 2025 //
GLOBENEWSWIRE
Zealand Pharma May Sell Future Obesity Drug Direct to Patients
23 Sep 2025 //
REUTERS
Zealand Pharma`s Capital Markets Day in London, Dec 11, 2025
11 Sep 2025 //
GLOBENEWSWIRE
Zealand Pharma Boost Share Capital via Employee Warrants Exercise
11 Sep 2025 //
GLOBENEWSWIRE
Zealand Announces Major Shareholder: Van Herk Investments B.V.
20 Aug 2025 //
GLOBENEWSWIRE
Zealand Pharma reports first-half 2025 financial results
14 Aug 2025 //
GLOBENEWSWIRE
Zealand Pharma to Present Q2 2025 Financial Results
07 Aug 2025 //
GLOBENEWSWIRE
Van Herk Investments B.V. Announces Major Stake in Zealand Pharma
18 Jul 2025 //
GLOBENEWSWIRE
Zealand`s Dual Agonist Tied to 11% Weight Loss in Phase 1b
20 Jun 2025 //
FIERCE BIOTECH
Zealand Reports Positive Ph1b Results for Dapiglutide
18 Jun 2025 //
GLOBENEWSWIRE
Zealand Seeks EMA Nod for Glepaglutide in Short Bowel Syndrome
02 Jun 2025 //
GLOBENEWSWIRE
Zealand Pharma Shares Transactions by Company Insiders
27 May 2025 //
GLOBENEWSWIRE
Zealand Pharma to Join Healthcare Investor Conferences May-June
12 May 2025 //
GLOBENEWSWIRE
Zealand Pharma closes deal with Roche
09 May 2025 //
GLOBENEWSWIRE
Zealand Pharma enrolls first participant in Ph 2b ZUPREME-2 trail
24 Apr 2025 //
GLOBENEWSWIRE
Zealand Pharma names Utpal Singh Chief Scientific Officer
23 Apr 2025 //
GLOBENEWSWIRE
Zealand Pharma`s shares and voting rights as of March 31, 2025
31 Mar 2025 //
GLOBENEWSWIRE
Zealand Pharma raises share capital through employee warrants
20 Mar 2025 //
GLOBENEWSWIRE
Zealand Pharma conference call to present full year 2024 results
13 Feb 2025 //
GLOBENEWSWIRE
Zealand Pharma Reports Transactions By Managerial Personnel
13 Jan 2025 //
GLOBENEWSWIRE
Zealand Pharma Appoints Steven R. Smith As Global Medical Advisor
07 Jan 2025 //
GLOBENEWSWIRE
Zealand Pharma Enrolls 1st Participant in Phase 2b ZUPREME-1 Trial
10 Dec 2024 //
GLOBENEWSWIRE
Zealand Pharma to Attend Jefferies London Healthcare Conf.
13 Nov 2024 //
GLOBENEWSWIRE
Zeal& Pharma Share Transactions by Management & Associated Persons
11 Nov 2024 //
GLOBENEWSWIRE
Zealand Pharma Starts Phase 2b Trial for Obesity Drug in Q4
07 Nov 2024 //
REUTERS
Zealand Pharma to Present Q3 2024 Financial Results on Nov 7
01 Nov 2024 //
GLOBENEWSWIRE
Zealand Pharma Provides Update On Dasiglucagon In CHI
09 Oct 2024 //
GLOBENEWSWIRE
FDA declines to approve Zealand drug for low blood sugar in infants
09 Oct 2024 //
REUTERS
Zealand Pharma To Attend 2024 Cantor Global Healthcare Conference
13 Sep 2024 //
GLOBENEWSWIRE
Zealand Pharma Increases Share Capital From Employee Warrants
12 Sep 2024 //
GLOBENEWSWIRE
Total number of shares and voting rights in Zealand Pharma on August 30, 2024
30 Aug 2024 //
GLOBENEWSWIRE
Zealand Pharma Reports Transactions In Shares By Management
30 Aug 2024 //
GLOBENEWSWIRE
